ASSURE Wearable ECG vs KardiaAI
AI Verdict
Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if you require a comprehensive, continuous, and comfortable long-term ECG monitoring solution for at-risk cardiac patients. This tool is ideal for situations demanding robust motion artifact filtering and seamless integration with a dedicated remote patient data platform for clinician review and ongoing management.
View ASSURE Wearable ECG →Choose KardiaAI if…
Choose KardiaAI if you need to integrate an FDA-cleared, AI-powered ECG analysis library into existing mobile applications, web platforms, or other ECG devices. This solution is best suited for developers and healthcare providers looking to enhance their platforms with medical-grade accuracy for detecting various cardiac conditions from ambulatory ECG rhythms.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | KardiaAI |
|---|---|---|
| Pricing | Unknown | Subscription-based for advanced features and services. |
| Deployment | The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. | Mobile app, cloud-based. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ASSURE Wearable ECGTool A, the ASSURE Wearable ECG, emphasizes an 'intuitive' design with a complete system including a wearable device, mobile application, and a cloud-based platform. This integrated approach suggests a more direct and user-friendly experience for both patients and clinicians compared to Tool B, which is primarily an API library requiring integration into other platforms.
Clinical Value
ASSURE Wearable ECGBoth tools are FDA-cleared and offer significant clinical value in cardiology. Tool A provides continuous heart rate monitoring, physiologic trend data, automatic episode storage, and alert-based notifications through its Kestra CareStation, offering a comprehensive approach to ongoing patient management. While Tool B offers a broad range of specific arrhythmia detections, Tool A's continuous monitoring and integrated clinician platform provide a more holistic and proactive clinical management solution.
Pricing & Value
KardiaAITool B, KardiaAI, offers clear and transparent subscription-based pricing with multiple tiers (KardiaCare Monthly, Annual, Plus), allowing users to understand costs upfront. Tool A requires contacting for pricing, which makes it challenging to assess its value proposition without further inquiry.
Enterprise Readiness
KardiaAIBoth tools demonstrate strong foundational enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability. However, Tool B, as an API library, offers greater flexibility for integration into diverse existing enterprise systems and custom workflows. This adaptability is a key advantage for large organizations looking to embed AI capabilities into their specific healthcare IT infrastructure.
Innovation
ASSURE Wearable ECGTool A showcases specific technological innovations such as its 'SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors,' 'Quad Channel Processingu2122,' and 'Adaptive Patient Intelligenceu2122' for motion artifact filtering. These details provide concrete examples of novel approaches in hardware and signal processing. Tool B, while offering 'medical-grade AI solutions,' describes its innovation in more general terms.
Support & Docs
TieNeither the provided structured facts nor a general web search offered specific, comparable details regarding the depth and availability of support channels or documentation for either tool. While both companies likely offer support, there isn't enough information to definitively pick a winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | KardiaAI |
|---|---|---|
| Name | ASSURE Wearable ECG | KardiaAI |
| Company | Kestra Medical Technologies | AliveCor |
| Description | A non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI |
| Key Features (ECG Analysis) | Continuous heart rate monitoring, ASSURE Detection Algorithm with Quad Channel Processingu2122, Adaptive Patient Intelligenceu2122 for filtering motion artifacts | AI-powered ECG analysis library, Detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE), ECG noise filtering and noisy ECG detection |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring ASSURE Wearable ECG or KardiaAI
Backers
Who funded each tool's parent company.